Skytrofa’s once weekly dose for growth hormone deficiency depends on your child’s body weight and response to the drug. It is important to follow the Skytrofa dosage a doctor prescribes. Skytrofa is a ...

Skytrofa is a brand-name injection prescribed for growth hormone deficiency (GHD) in children. Skytrofa contains the active ingredient lonapegsomatropin and belongs to the growth hormone drug class.

Skytrofa (lonapegsomatropin-tcgd) is a prescription drug that’s used to treat growth hormone deficiency (GHD) in certain children. It’s given by injection under the skin once weekly. Skytrofa is a ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Ascendis Pharma announced that the US Food and Drug Administration (FDA) has approved Skytrofa (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11 ...

SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Australian registration of SKYTROFA® (lonapegsomatropin) as a new ...